Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Hack

Showing results (191-200 of 369) with videos related to

Pageof 37
Sort By:
Clinical and Experimental Immunology|January 1, 1984
SLE like syndrome and functional deficiency of C1q in members of a large familyA J Hannema, J C Kluin-Nelemans, C E Hack, et al.
Transplantation Proceedings|December 1, 1994
Increased levels of sTNF receptors following OKT3 treatmentF J Bemelman, J Jansen, T van der Poll, et al.
Biophysical Journal|May 8, 1999
A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometryM Robers, I J Rensink, C E Hack, et al.
Thrombosis and Haemostasis|March 1, 1995
Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic feverM V Heller, R F Marta, A Sturk, et al.
Thrombosis and Haemostasis|June 1, 1997
Effects of heparin therapy on fibrinolysis in patients with pulmonary embolismM C Minnema, H ten Cate, E J van Beek, et al.
Journal of Immunological Methods|July 6, 1993
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathwayG J Wolbink, J Bollen, J W Baars, et al.
British Journal of Cancer|March 1, 1994
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2A C Ogilvie, J W Baars, A J Eerenberg, et al.
Lancet (London, England)|October 17, 1987
Serum levels of interleukin-6 and acute phase responsesM W Nijsten, E R de Groot, H J ten Duis, et al.
Intensive Care Medicine|January 1, 1990
A model for the interplay of inflammatory mediators in sepsis--a study in 48 patientsC E Hack, J H Nuijens, R J Strack van Schijndel, et al.
Clinical Nephrology|March 10, 1998
Apoptotic tubular cell death during acute renal allograft rejectionP C Wever, J Aten, R J Rentenaar, et al.
Pageof 37

Showing results (191-200 of 369) with videos related to

Sort By:
Pageof 37
Clinical and Experimental Immunology|January 1, 1984
SLE like syndrome and functional deficiency of C1q in members of a large familyA J Hannema, J C Kluin-Nelemans, C E Hack, et al.
Transplantation Proceedings|December 1, 1994
Increased levels of sTNF receptors following OKT3 treatmentF J Bemelman, J Jansen, T van der Poll, et al.
Biophysical Journal|May 8, 1999
A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometryM Robers, I J Rensink, C E Hack, et al.
Thrombosis and Haemostasis|March 1, 1995
Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic feverM V Heller, R F Marta, A Sturk, et al.
Thrombosis and Haemostasis|June 1, 1997
Effects of heparin therapy on fibrinolysis in patients with pulmonary embolismM C Minnema, H ten Cate, E J van Beek, et al.
Journal of Immunological Methods|July 6, 1993
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathwayG J Wolbink, J Bollen, J W Baars, et al.
British Journal of Cancer|March 1, 1994
A pilot study to evaluate the effects of C1 esterase inhibitor on the toxicity of high-dose interleukin 2A C Ogilvie, J W Baars, A J Eerenberg, et al.
Lancet (London, England)|October 17, 1987
Serum levels of interleukin-6 and acute phase responsesM W Nijsten, E R de Groot, H J ten Duis, et al.
Intensive Care Medicine|January 1, 1990
A model for the interplay of inflammatory mediators in sepsis--a study in 48 patientsC E Hack, J H Nuijens, R J Strack van Schijndel, et al.
Clinical Nephrology|March 10, 1998
Apoptotic tubular cell death during acute renal allograft rejectionP C Wever, J Aten, R J Rentenaar, et al.
Pageof 37